12:00 AM
Aug 13, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: HECT domain containing E3 ubiquitin protein ligase 2 (HECTD2)


INDICATION: Inflammation; pulmonary

Mouse studies suggest inhibiting HECTD2 could help treat lung inflammation. In a mouse model of pneumonia, pretreatment with a lentiviral vector encoding HECTD2 increased...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >